TD Cowen Keeps Their Buy Rating on Universal Health (UHS)
TipRanks (Tue, 4-Mar 7:47 AM ET)
Play defense with Goldman's cheap healthcare picks
Seeking Alpha News (Sun, 2-Mar 12:27 PM ET)
Seeking Alpha News (Sun, 2-Mar 11:05 AM ET)
Hospital stocks fall amid Medicaid funding concerns
Seeking Alpha News (Fri, 28-Feb 12:26 PM ET)
TipRanks (Fri, 28-Feb 7:30 AM ET)
PRNewswire (Wed, 26-Feb 4:16 PM ET)
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MARCH HEALTHCARE CONFERENCES
PRNewswire (Fri, 21-Feb 4:30 PM ET)
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
PRNewswire (Wed, 12-Feb 4:30 PM ET)
PRNewswire (Wed, 22-Jan 4:30 PM ET)
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
Universal Health Services trades on the NYSE stock market under the symbol UHS.
As of March 5, 2025, UHS stock price climbed to $177.72 with 1,137,640 million shares trading.
UHS has a beta of 0.80, meaning it tends to be less sensitive to market movements. UHS has a correlation of 0.09 to the broad based SPY ETF.
UHS has a market cap of $11.55 billion. This is considered a Large Cap stock.
Last quarter Universal Health Services reported $4 billion in Revenue and $4.92 earnings per share. This beat revenue expectation by $104 million and exceeded earnings estimates by $.74.
In the last 3 years, UHS traded as high as $243.25 and as low as $82.50.
The top ETF exchange traded funds that UHS belongs to (by Net Assets): VTI, VOO, VB, VBR, RSP.
UHS has underperformed the market in the last year with a return of +2.2%, while the SPY ETF gained +15.2%. In the last 3 month period, UHS fell short of the market, returning -10.6%, while SPY returned -3.7%. However, in the most recent 2 weeks UHS has outperformed the stock market by returning -2.8%, while SPY returned -4.6%.
UHS support price is $170.02 and resistance is $176.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that UHS shares will trade within this expected range on the day.